Zobrazeno 1 - 8
of 8
pro vyhledávání: '"LR López Giménez"'
Autor:
S Mendiola Garcia, LR López Giménez, B San Jose Ruiz, A Belaustegui Foronda, A De Basagoiti Gorordo, G Ros Bernaola
Publikováno v:
European Journal of Hospital Pharmacy. 23:A148.1-A148
Background Patients with chemosensitive neuroendocrine tumours are often treated with a capecitabine protocol (750 mg/m2/12 h day 1 to day 14) and temozolomide (200 mg/m2/24 h day 10 to day 14). A patient treated with this protocol in our centre pres
Autor:
M Castaño Lopez, A Belaustegui Foronda, G Ros Bernaola, B San Jose Ruiz, I Bilbao Meseguer, LR López Giménez, A Bustinza Txertudi, B Sordo Aisa, A De Basagoiti Gorordo, Z Baskaran Kaltzakorta
Publikováno v:
European Journal of Hospital Pharmacy. 22:A128.1-A128
Background Patients with tuberous sclerosis often develop facial angiofibromas that can be successfully treated with topical 1% sirolimus ointments. Nevertheless, this ointment’s greasy nature can produce acne, causing patients to refuse the treatm
Autor:
E Martinez de Ilarduya Bolado, D Gómez Gómez, LR López Giménez, C Abraira Meriel, M Gómez Martínez, M Valero Domínguez, A Gómez Esteban, MA Martín Vega, E Sanchez Acera, A Colón López de Dicastillo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A156.2-A156
Background Errors in prescribing antiretroviral treatment (ART) are common during the hospitalisation of HIV patients. Interventions to prevent and correct errors improve the quality of health care. Purpose To describe the pharmaceutical intervention
Autor:
LR López Giménez, M Valero Domínguez, D Gómez Gómez, C Abraira Meriel, E Martinez de Ilarduya Bolado, JJ Martínez Garde, A Gómez Esteban, E Sanchez Acera, I Angulo López, A Colón López de Dicastillo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A1.1-A1
Background Inappropriate antimicrobial treatment in bloodstream infections is associated with increased mortality rates and health cost. Purpose To assess the adequacy and modification of empirical treatment, according to preliminary and final microb
Autor:
E Martinez de Ilarduya Bolado, A Colón López de Dicastillo, A Gómez Esteban, C Abraira Meriel, LR López Giménez, JJ Martínez Garde, M Valero Domínguez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A38.1-A38
Background The imiglucerase drug shortages in 2009 forced a change in the treatment of many patients with Gaucher’s disease. Purpose To describe the clinical outcomes of an adult patient with type 1 Gaucher’s disease (GD1) after discontinuation o
Autor:
LR López Giménez, C Abraira Meriel, JJ Martínez Garde, MA Martín Vega, M Valero Domínguez, Rivas Santayana, A Gómez Esteban
Publikováno v:
European Journal of Hospital Pharmacy. 20:A18.1-A18
Background A safety problem occurred in requesting enteral diets (EDs) in the neonatal unit. So we decided to develop a special prescription module for requesting EDs. Purpose To describe the design and development of a prescription and request modul
Autor:
De Basagoiti A; Biocruces Bizkaia Health Research Institute, Pharmacotherapy and Drug Safety Group, Barakaldo, Bizkaia, Spain.; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain., Katsumiti A; Biocruces Bizkaia Health Research Institute, Pharmacotherapy and Drug Safety Group, Barakaldo, Bizkaia, Spain., Abascal S; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain., Bustinza A; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., López-Giménez LR; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain., Pascual P; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain., De Miguel M; Biocruces Bizkaia Health Research Institute, Pharmacotherapy and Drug Safety Group, Barakaldo, Bizkaia, Spain.; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain., Campino A; Biocruces Bizkaia Health Research Institute, Pharmacotherapy and Drug Safety Group, Barakaldo, Bizkaia, Spain. ainara.campinovillegas@osakidetza.eus.; Osakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Bizkaia, Spain. ainara.campinovillegas@osakidetza.eus.
Publikováno v:
European journal of pediatrics [Eur J Pediatr] 2021 Apr; Vol. 180 (4), pp. 1169-1176. Date of Electronic Publication: 2020 Oct 31.
Autor:
San José Ruiz B; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España. Electronic address: begona.sanjoseruiz@osakidetza.eus., Serrano De Lucas L; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España., López-Giménez LR; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España., Baza Martínez B; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España., Sautua Larreategi S; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España., Bustinza Txertudi A; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España., Sebastián Leza Á; Servicio de Medicina Interna, Hospital Universitario Cruces, Barakaldo, España., Chirivella Ramón MT; Servicio de Cirugía Vascular y Angiología, Hospital Universitario Cruces, Barakaldo, España., Fonseca Legrand JL; Servicio de Cirugía Vascular y Angiología, Hospital Universitario Cruces, Barakaldo, España., de Miguel Cascon M; Servicio de Farmacia, Hospital Universitario Cruces, Barakaldo, España.
Publikováno v:
Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial [Rev Calid Asist] 2016 Jun; Vol. 31 Suppl 1, pp. 36-44. Date of Electronic Publication: 2016 May 05.